Current as of July 19, 2026 Settlement being finalized. Rules for who’s covered not yet public.

The Depo-Provera settlement is being finalized. See where you stand.

If you or someone you love used the depo shot and were later diagnosed with meningioma, this page tracks where things stand for you, plainly.

See where you stand

Takes under a minute. Your name isn’t asked until you choose to continue.

Answer two questions and see where you stand

The Depo-Provera Watch Current as of July 19, 2026

Settlement Agreement in principle, terms being finalized June 15 · court order

Who is covered Eligibility rules not yet published As of July 19

Case count 5,830 pending in the court record Court record · July 1

Every line above is sourced and dated.

The short version

What’s happening, in plain terms.

Depo-Provera is a birth-control shot that millions of women received, many of them in the 1990s and 2000s. In recent years, published studies linked long-term use of the shot to meningioma, a brain tumor that’s usually not cancerous, and regulators added a warning to the label. Thousands of women have taken it to court.

In June 2026, Pfizer reached an agreement in principle to settle. The terms are still being written, the rules for who’s covered aren’t public yet, and the court is still taking new cases. That’s the whole picture today. The rest of this page walks through what it means for you.

Read the full picture in Answers

How this works

The check, in three plain steps.

One
You answer two questions. No name, phone, or email to start.
Two
You see where you stand against what the court record shows today.
Three
You decide what happens next. Nothing is signed and there’s no cost.

See where you stand

The honest self-screen

Does this reach you?

Three things put a woman inside this story. None of them needs paperwork to check.

You used Depo-Provera, the depo shot.
Even decades ago. Many of the women in the court record received it in the 1990s or 2000s, often starting in their early 30s.
Your use ran long.
Firms filing cases today usually look for at least two injections, and the published science found the risk concentrates after four or more years of use.
You were later diagnosed with meningioma.
Confirmed by an MRI or CT scan, after you started the shot. Not sure yet? The check meets you there too.

One thing said plainly: these aren’t the settlement’s eligibility rules. Those haven’t been made public, by anyone. This is the honest read of what filing firms look for and where the published science points today.

See where you stand

What the science says

Meningioma, stated precisely.

Meningioma is a brain tumor that’s usually not cancerous. That doesn’t make it minor. It can mean surgery, lasting neurological change, and monitoring for years. Long-term use of the depo shot has been linked to it, and regulators have added a meningioma warning to the label. Whether the shot caused any one woman’s tumor is the exact question the court hasn’t ruled on yet.

Peer-reviewed study BMJ 2024
A national case-control study of progestogen use and intracranial meningioma.
Peer-reviewed study JAMA Neurology 2025
A cohort study of 10.4 million US women, on medroxyprogesterone acetate and meningioma risk.
Regulatory action FDA December 2025
Meningioma added to the Depo-Provera label under Warnings and Precautions, Section 5.4.
Federal docket The court record MDL 3140
In re: Depo-Provera, N.D. Florida. The case status on this page reads from this docket.

Read the full picture in Answers

See where you stand

Checking for someone you love

Reading this for your mom?

A lot of the people on this page aren’t the ones who got the shot. They’re daughters, sons, and spouses doing the careful reading for someone they love. The check works the same on her behalf: it starts with her answers, not her name.

Start the check on her behalf

Who keeps this Watch

Independent, sourced, and dated.

DepoWatch is an independent settlement watch. It does one job: track the Depo-Provera litigation as the court record actually shows it, and keep that read current. Every status line on this site carries its source and its date. And when something isn’t known yet, like who the settlement will cover, the page says so instead of guessing.

See where you stand

5,830 women and families on the record Court record · July 1, 2026

That count is the community this Watch is kept for.

How the record has moved

FDA adds label warningDecember 2025

Agreement in principleJune 15, 2026

5,830 cases pendingCourt record, July 1

Eligibility rulesNot yet public

See where you stand

Plain answers

Questions women are asking.

Is there a deadline to join the Depo-Provera lawsuit?

No. As of July 19, 2026, no registration deadline or claim cutoff has been published, by the court or by anyone else. That absence is itself a verified fact, and when a real date exists this page will carry it, sourced and dated.

Read the full picture in Answers

Is it too late to file a Depo-Provera claim?

No. The court is still taking new cases, and the official pending count grew after the settlement announcement, from 5,508 on June 1 to 5,830 on July 1, 2026. Intake is open today.

See where you stand

Do I qualify for the Depo-Provera settlement?

Nobody can answer that honestly yet, because the settlement’s eligibility rules haven’t been made public. What you can do today is see where you stand against what filing firms look for: use of the shot, and a meningioma diagnosis that came after it.

See where you stand

What is meningioma?

Meningioma is a brain tumor that’s usually not cancerous. That doesn’t make it minor: it can mean surgery, lasting neurological change, and monitoring for years.

Read what a meningioma diagnosis means

How much is the Depo-Provera settlement worth?

No dollar amount has been disclosed, for the settlement overall or for any one case. Any figure you see quoted right now is an attorney’s estimate, not a court-approved term, and this page won’t print a number until one is real.

Read the full picture in Answers

When will the Depo-Provera lawsuit be settled?

Pfizer and the plaintiffs reached an agreement in principle on June 15, 2026, and the parties are still writing the final terms. No completion date has been published, so any date you see elsewhere is a guess.

Read the full picture in Answers

See where you stand